Key TakeawaysUK retail investors are facing delays before they can purchase regulated crypto assets, according to reports from the Financial Times.Goldman Sachs (GS) warns of a potential stock market drawdown in the next one to two years, despite current bullishness driven by AI trade excitement, with CEO David Solomon expressing skepticism about the rapid pace of gains.OPEC+ is reportedly poised to implement another oil production hike, as major producers like Saudi Arabia and Russia engage in discussions ...

诉讼案件概述 - 美国特拉华州一名法官裁定动视暴雪前高管必须面对诉讼的大部分指控 [1] - 诉讼指控高管在微软收购动视暴雪的交易中损害了股东利益 [1] - 诉讼涉及动视暴雪前首席执行官Bobby Kotick等多名前公司官员 [1] 诉讼核心内容 - 诉讼核心是动视暴雪前高管被指控在微软收购交易中使股东蒙受损失 [1] - 诉讼与微软收购动视暴雪的交易直接相关 [1] - 诉讼涉及的游戏资产包括《Call of Duty》等知名游戏系列 [1]

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Nutex (NUTX) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Nutex between August 8, 2024 and August 14, 2025and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar ...

SYDNEY & CHICAGO--(BUSINESS WIRE)--James Hardie Industries plc (NYSE / ASX: JHX) ("James Hardie†or the "Company†), a global leader in high-performance building product solutions, today announced the appointment of Samara (Sam) Toole as Chief Marketing Officer (CMO). As a member of the executive leadership team, Toole will lead marketing strategy and execution across the company's portfolio, including the James Hardie®, TimberTech®, and AZEK Exteriors® brands. "This is an incredibly exciting mo. ...

LOS ANGELES, Oct. 03, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion. Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to fcruz@frankcruzlaw.com. RCI ...

The U.S. stock market continued its remarkable ascent on Friday, October 3, 2025, with major indexes not only holding their ground but surging to new all-time highs, largely shrugging off the ongoing government shutdown and maintaining a robust upward trend. This sustained rally, characterized by strong midday trading patterns and significant market momentum, is primarily fueled by the transformative power of Artificial Intelligence (AI), robust corporate earnings, and persistent expectations of future mone ...

No jobs report and a lack of economic data cloud the picture. But you can still make informed portfolio moves. ...

Key Takeaways Constellation Brands is set to post Q2 FY26 revenues of $2.5B, down 15.8% from last year.Earnings are expected at $3.37 per share, a 21.9% year-over-year decline.Beer brands like Modelo and Corona stay strong, offsetting softness in wine and spirits.Constellation Brands, Inc. (STZ) is scheduled to release second-quarter fiscal 2026 results on Oct. 6, 2025. The alcoholic beverage bigwig is expected to have recorded a decline in its top and bottom lines in the to-be-reported quarter.The Zacks Co ...

In exchange for selling the bull put spread, the trader receives the option premium and also has risk equal to the difference in strike prices, less the premium received. The Bull Put Spread Trade Setup Celestica (CLS) stock has been in a great uptrend since April and could be a good candidate for bullish option traders. Traders looking for a way to play Celestica stock using options could use a bull put spread. As a reminder, a bull put spread is a defined risk strategy. You always know the worst-case scen ...

2025 has been a cornucopia of massive updates for companies exploring new possibilities in targeting the RAS/MAPK signaling pathway for cancer. I am notably excited about the prospects of companies likeI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfalls of investing i ...